slv-351
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2008 (NCT00581191)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- NeprilysinINHIBITOR
MME inhibitor
- Endothelin-converting enzyme 1INHIBITOR
ECE1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- slv-351
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00581191 | Phase 1 | Jan 1, 2008 | Pfizer, Solvay, Wyeth |
Showing 1 of 1 trials
Page 1 / 1